Chirocaine

Active Ingredient(s): Levobupivacaine
FDA Approved: * August 5, 1999
Pharm Company: * PURDUE PHARMA LP
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Chirocaine Overview

Levobupivacaine (rINN) /livobjupvken/ is a local anaesthetic drug belonging to the amino amide group. It is the S-enantiomer of bupivacaine.[1] Levobupivacaine hydrochloride is commonly marketed by AbbVie under the trade name Chirocaine.[2] Contents 1 Clinical use 1.1 Indications 1.2 Contraindications 1.3 Adverse effects 1.4 Postarthroscopic glenohumeral chondrolysis 2 References Clinical use Compared to bupivacaine, levobupivacaine is associated wi...

Read more Chirocaine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Levobupivacaine

Recent Chirocaine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Levobupivacaine
  • Injection: 2.5mg/ml, 5mg/ml, 7.5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Levobupivacaine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA